Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

American health insurer will only pay for BRCA test after genetic counselling

27 August 2013

By Simon Hazelwood-Smith

Appeared in BioNews 719

For the first time, a major health insurance company in the USA will require its customers to receive genetic counselling before it will pay for certain genetic tests.

On 16 September, Cigna will introduce its policy stipulating that anyone considering testing for the breast cancer susceptibility genes BRCA1 and BRCA2 must first consult with an approved genetic counsellor.

'We want to make sure these tests are being used according to national guidelines, that our customers are receiving good quality care and that we are not paying for tests with no clinical value', Dr David Finley, a national medical officer for Cigna, told Bloomberg.

Dr Finley added that the tests 'are commonly performed, they have big consequences and they are frequently misunderstood', suggesting that part of the rationale behind the decision was to reduce imprecisions communicated by healthcare staff with minimal training in genetics.

The policy, which also includes testing for genes involved in hereditary colon cancer and the heart condition long QT syndrome, has provoked a mixed reaction.

Rebecca Nagy, president of the National Society of Genetic Counsellors, said: 'We applaud Cigna for recognising the important role genetic counsellors play to help someone make a truly informed decision so the right person receives the right test at the right time'.

'Too often the wrong family member is tested or the wrong test is ordered. This policy will help ensure that Cigna customers receive appropriate testing that will lead to better health outcomes'. A 2010 report from ARUP Laboratories, a pathology reference library, found that 30 percent of complex genetic tests commissioned were delivered with some error in handling by the ordering doctor.

However some commentators are concerned that the policy's guidelines on counselling provision, which include a telephone-only service, may cause problems. Speaking to the Boston Herald, Dr Aubrey Milunsky of the Centre for Human Genetics in Cambridge, Massachusetts, said: 'In our business telephone counselling is a no-no'. He added that specialist medical doctors are better placed to give advice on genetic testing.

Others fear that the policy may be a cost-cutting measure. Joshua Archambault of the Pioneer Institute, a public policy non-profit organisation based in Boston, told the Boston Herald: 'If the counselling is solely used as a cost-containment measure, patients are likely to be unhappy'.

News of the policy triggered a fall in the share price of Myriad, who hold patents on BRCA gene testing, following concern that demand will fall. Ellen Matloff, head of cancer genetic counselling at the Yale Cancer Center, told Bloomberg that the news was 'bad for Myriad's business' as counsellors may advise clients not to get tested as their cancer risk is low or may recommend tests by rival companies.

SOURCES & REFERENCES
Bloomberg | 19 August 2013
 
SF Gate | 20 August 2013
 
Boston Herald | 20 August 2013
 
National Society of Genetic Counselors (press release) | 23 July 2013
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

15 September 2014 - by Dr Rachel Brown 
A leading scientist involved in the identification of the BRCA1 gene mutation has recommended that genetic screening of the BRCA genes should be routinely offered to all women aged 30 years or over....
17 March 2014 - by Patricia Cassidy 
Myriad Genetics has failed to obtain a preliminary injunction to prevent a competitor, Ambry Genetics, from offering BRCA-related genetic testing products...
02 December 2013 - by Dr Charlotte Warren-Gash 
Women from families with a history of carrying the cancer risk gene BRCA2, but who test negative for it, may be at higher risk of breast cancer than previously thought...
07 October 2013 - by Ruth Retassie 
A London clinic has reported an increase in the number of requests for BRCA genetic testing and preventative mastectomies since Angelina Jolie's announcement last May that she had undergone a double mastectomy....
09 September 2013 - by Alastair Kent and Nick Meade 
This week, the new policy of American health insurer, Cigna, that requires genetic counselling before access to BRCA genetic testing, will come into effect. Reaction to this announcement has been mixed. We thought it would be interesting to compare this new policy with how genetic testing for BRCA cancer risk is delivered in the UK....

15 July 2013 - by Ruth Retassie 
Myriad Genetics is suing two other companies who are offering genetic tests for BRCA1 and BRAC2 gene mutations for patent infringement...
02 July 2012 - by George Frodsham 
People who undergo genetic testing to establish their future risk of developing a genetic condition, such as Alzheimer's or breast cancer, will continue to have the right to take out health insurance without disclosing the test results to their insurer....
22 November 2010 - by MacKenna Roberts 
The Equal Employment Opportunity Commission (EEOC), responsible for enforcing federal anti-discrimination laws in the US, has issued its 'final rule' guidelines clarifying how federal laws should operate to prevent job discrimination on the basis of genetic information....
14 September 2009 - by Rosie Beauchamp 
A study published in the Medical Journal of Australia indicates that up to 50 per cent of Australians could be refusing genetic tests due to the fear that the test outcomes will result in increased health insurance premiums or refusal to insure them altogether. In Australia, genetic information does not inform health insurance. However, it may affect insurance policies that cover trauma, disability, sickness and accidents. Applicants for such health insurance policies have a statutory duty to...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation